Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

NCT04127721 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped 0 ACTUAL Enrollment must have Overall Recruitment Status

Conditions

Allogeneic Stem Cell Transplant Recipient
Hematologic and Lymphocytic Disorder
Hematopoietic and Lymphoid Cell Neoplasm

Interventions

PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Busulfan
DRUG: Fludarabine
DRUG: Itacitinib
DRUG: Methotrexate
DRUG: Tacrolimus

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]